These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 36241089

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Targeted Analysis of Sphingolipids in Turkeys Fed Fusariotoxins: First Evidence of Key Changes That Could Help Explain Their Relative Resistance to Fumonisin Toxicity.
    Guerre P, Travel A, Tardieu D.
    Int J Mol Sci; 2022 Feb 24; 23(5):. PubMed ID: 35269655
    [Abstract] [Full Text] [Related]

  • 3. Targeted sphingolipidomics indicates increased C22-C24:16 ratios of virtually all assayed classes in liver, kidney, and plasma of fumonisin-fed chickens.
    Lassallette E, Collén PN, Guerre P.
    Ecotoxicol Environ Saf; 2023 Dec 24; 268():115697. PubMed ID: 37979349
    [Abstract] [Full Text] [Related]

  • 4. Targeted Sphingolipid Analysis in Heart, Gizzard, and Breast Muscle in Chickens Reveals Possible New Target Organs of Fumonisins.
    Guerre P, Gilleron C, Matard-Mann M, Nyvall Collén P.
    Toxins (Basel); 2022 Nov 24; 14(12):. PubMed ID: 36548725
    [Abstract] [Full Text] [Related]

  • 5. Strong Alterations in the Sphingolipid Profile of Chickens Fed a Dose of Fumonisins Considered Safe.
    Tardieu D, Matard-Mann M, Collén PN, Guerre P.
    Toxins (Basel); 2021 Oct 30; 13(11):. PubMed ID: 34822554
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Fumonisin B1 inhibits sphingosine (sphinganine) N-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ.
    Merrill AH, van Echten G, Wang E, Sandhoff K.
    J Biol Chem; 1993 Dec 25; 268(36):27299-306. PubMed ID: 8262970
    [Abstract] [Full Text] [Related]

  • 8. Fumonisins alone or mixed with other fusariotoxins increase the C22-24:C16 sphingolipid ratios in chicken livers, while deoxynivalenol and zearalenone have no effect.
    Guerre P, Lassallette E, Beaujardin-Daurian U, Travel A.
    Chem Biol Interact; 2024 May 25; 395():111005. PubMed ID: 38615975
    [Abstract] [Full Text] [Related]

  • 9. Ceramide synthase inhibition by fumonisins: a perfect storm of perturbed sphingolipid metabolism, signaling, and disease.
    Riley RT, Merrill AH.
    J Lipid Res; 2019 Jul 25; 60(7):1183-1189. PubMed ID: 31048407
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Fumonisin B1 induces apoptosis in cultured human keratinocytes through sphinganine accumulation and ceramide depletion.
    Tolleson WH, Couch LH, Melchior WB, Jenkins GR, Muskhelishvili M, Muskhelishvili L, McGarrity LJ, Domon O, Morris SM, Howard PC.
    Int J Oncol; 1999 May 25; 14(5):833-43. PubMed ID: 10200332
    [Abstract] [Full Text] [Related]

  • 16. Increases in serum sphingosine and sphinganine and decreases in complex sphingolipids in ponies given feed containing fumonisins, mycotoxins produced by Fusarium moniliforme.
    Wang E, Ross PF, Wilson TM, Riley RT, Merrill AH.
    J Nutr; 1992 Aug 25; 122(8):1706-16. PubMed ID: 1640265
    [Abstract] [Full Text] [Related]

  • 17. Disruption of sphingolipid metabolism and stimulation of DNA synthesis by fumonisin B1. A molecular mechanism for carcinogenesis associated with Fusarium moniliforme.
    Schroeder JJ, Crane HM, Xia J, Liotta DC, Merrill AH.
    J Biol Chem; 1994 Feb 04; 269(5):3475-81. PubMed ID: 8106389
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Sphingolipid biosynthesis de novo by rat hepatocytes in culture. Ceramide and sphingomyelin are associated with, but not required for, very low density lipoprotein secretion.
    Merrill AH, Lingrell S, Wang E, Nikolova-Karakashian M, Vales TR, Vance DE.
    J Biol Chem; 1995 Jun 09; 270(23):13834-41. PubMed ID: 7775441
    [Abstract] [Full Text] [Related]

  • 20. New insights into the organ-specific adverse effects of fumonisin B1: comparison between lung and liver.
    Loiseau N, Polizzi A, Dupuy A, Therville N, Rakotonirainy M, Loy J, Viadere JL, Cossalter AM, Bailly JD, Puel O, Kolf-Clauw M, Bertrand-Michel J, Levade T, Guillou H, Oswald IP.
    Arch Toxicol; 2015 Sep 09; 89(9):1619-29. PubMed ID: 25155190
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.